Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial

por Ahi, Mohammadreza, Hamidi Farahani, Ramin, Basiri, Pouria, Karimi Rahjerdi, Ahmad, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Gholami, Fatemeh, Moradi, Milad, Ghafoori Naeeni, Farzad, Saffar, Kosar Naderi, Ghasemi, Soheil, Barati, Babak, Moradi, Sohrab, Monazah, Arina, Pouranvari, Fatemeh, Forooghizadeh, Mohsen
Publicado 2022

Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

por Solaymani-Dodaran, Masoud, Basiri, Pouria, Moradi, Milad, Gohari, Kimiya, Sheidaei, Ali, Ahi, Mohammadreza, Ghafoori Naeeni, Farzad, Ansarifar, Akram, Rahimi, Zahra, Gholami, Fatemeh, Karimi Rahjerdi, Ahmad, Hamidi Farahani, Ramin, Naderi saffar, Kosar, Ghasemi, Soheil, Shooshtari, Ali, Honari, Mohsen, Mozafari, Ali, Khodaverdloo, Samane, Forooghizadeh, Mohsen
Publicado 2023